Ticker brief

ALKS ALKERMES PLC

Consumer, Non-cyclical · Pharmaceuticals

last close
$43.63
1 day
-1.2%
14 days
+7.4%
mkt cap
·
signals 14d
9
authors 14d
9
crowd 14d
+0.2σ
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-16 · now +0.19 (−1 bearish … +1 bullish)
Who spoke9
authorgradetrader scoresignalsmean sent
@Quantumup1C+0.101+0.40
@SandmanMarketsC+0.581+0.45
@OzmosiHealthC·1+0.10
@Maximus_HollaC-2.131-0.15
@PeloSwingC+1.051+0.45
@OpenOutcrierC·1+0.00
@CHItraderB-0.221+0.40
@zohmbasticC-2.941+0.00
@OptionsFlowBossC·1+0.35
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-16@OptionsFlowBoss+0.35Reports unusually bullish options volume multiples, mostly in energy stocks.+5.8%
2026-10-16@zohmbastic+0.00Notes put activity but explicitly says its direction is uncertain and may reflect short-position hedging.+5.8%
2026-10-16@CHItrader+0.40Multi-stock analyst coverage initiations with ratings and several price targets.+5.8%
2026-10-16@OpenOutcrier+0.00Lists October 16 analyst coverage initiations; ratings and firms are not provided.+5.8%
2026-10-15@PeloSwing+0.45Reports a $1.1M purchase of January 2028 $55 calls, implying a roughly 40% upside bet.+8.8%
2026-10-15@Maximus_Holla-0.15Author describes ALKS as an old favorite but says it is not playable now.+8.8%
2026-10-13@OzmosiHealth+0.10Alkermes will present new sleep-medicine data at Sleep Europe 2026.+9.8%
2026-10-06@SandmanMarkets+0.45Places ALKS on watch after OBV broke diagonal resistance, pending a future long trigger.+4.8%
2026-10-05@Quantumup1+0.40Stifel reiterated ALKS at Buy with a $63 target after meetings with management.+2.0%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.